LONDON BROKER RATINGS: Berenberg raises Vodafone; Barclays cuts Hikma
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More
| Price | 1,894.00p on 12-01-2026 at 12:30:45 |
|---|---|
| Change | 8.00p 0.42% |
| Buy | 1,894.50p |
| Sell | 1,893.50p |
| Last Trade: | Buy 70.00 at 1,893.87p |
| Day's Volume: | 3,242,978 |
| Last Close: | 1,886.00p |
| Open: | 1,879.50p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 1,870.50p - 1,902.00p |
| 52wk Range: | 1,242.50p - 1,909.50p |
| Market Capitalisation: | £76.41b |
| VWAP: | 1,882.20943p |
| Shares in Issue: | 4.03b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 70 | 1,893.87p | Ordinary |
12:30:29 - 12-Jan-26 |
| Buy* | 117 | 1,894.00p | Automatic Execution |
12:30:08 - 12-Jan-26 |
| Unknown* | 0 | 1,894.50p | SI Trade |
12:30:01 - 12-Jan-26 |
| Buy* | 12 | 1,894.50p | SI Trade |
12:30:01 - 12-Jan-26 |
| Unknown* | 0 | 1,894.50p | SI Trade |
12:30:01 - 12-Jan-26 |
| Sell* | 214 | 1,893.50p | Ordinary |
12:28:49 - 12-Jan-26 |
| Buy* | 195 | 1,894.50p | Automatic Execution |
12:28:47 - 12-Jan-26 |
| Buy* | 754 | 1,894.50p | Automatic Execution |
12:28:47 - 12-Jan-26 |
| Buy* | 848 | 1,894.50p | Automatic Execution |
12:28:47 - 12-Jan-26 |
| Buy* | 346 | 1,894.50p | Automatic Execution |
12:28:47 - 12-Jan-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 7th Jan 2026 7:05 am | RNS | EC approval of Shingrix PFS |
| 7th Jan 2026 7:00 am | RNS | Positive phase 3 data for GSK's bepirovirsen |
| 6th Jan 2026 7:00 am | RNS | Exdensur approved in Japan |
| 5th Jan 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 5th Jan 2026 3:00 pm | RNS | Total Voting Rights |
| 5th Jan 2026 7:00 am | RNS | Nucala for adults with COPD approved in China |
| 22nd Dec 2025 3:30 pm | RNS | Director/PDMR Shareholding |
| 22nd Dec 2025 3:30 pm | RNS | Director/PDMR Shareholding |
| 22nd Dec 2025 7:00 am | RNS | GSK to lower drug prices and expand access in US |
| 22nd Dec 2025 7:00 am | RNS | GSK to lower drug prices and expand access in US |